Ligand validation:6ZI4

NS5: 15-cis-1,2-dihydroneurosporene

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZI4_NS5_M_405	30%	19%	0.208	0.873	1.38	2.04	1	12	1	0	100%	1
2PRC_NS5_M_600	79%	47%	0.077	0.923	0.76	1.27	-	6	6	0	100%	0.65
6PRC_NS5_M_600	71%	51%	0.128	0.949	0.81	1.07	2	5	3	0	100%	0.65
5PRC_NS5_M_600	65%	46%	0.085	0.886	0.69	1.37	-	6	4	0	100%	0.65
3PRC_NS5_M_600	59%	53%	0.094	0.873	0.68	1.12	-	5	0	0	100%	0.775
1R2C_NS5_M_600	54%	54%	0.155	0.919	0.7	1.06	-	4	4	0	100%	0.725
3T6D_NS5_M_600	52%	8%	0.143	0.899	1.82	2.72	12	14	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.